U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT07559682) titled 'Efficacy of Selective COX-2 Inhibitors in Relieving Orthodontic Pain' on April 14.
Brief Summary: The purpose of this study is to compare the efficacy of selective COX-2 inhibitors{ etoricoxib vs celecoxib )in relieving orthodontic pain , after initial bonding and arch wire insertion.
Study Start Date: May 08, 2025
Study Type: INTERVENTIONAL
Condition:
Orthodontic Pain (D013850)
Intervention:
DRUG: Celecoxib
Group A will be given Celecoxib 50mg once a day.
DRUG: Etoricoxib (Treatment Group)
Group B will be given Etoricoxib 60mg once a day.
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: Sharif Medical Research Center
Di...